135 related articles for article (PubMed ID: 11981059)
1. Reduced 11beta-hydroxysteroid dehydrogenase activity in experimental nephrotic syndrome.
Vogt B; Dick B; Marti HP; Frey FJ; Frey BM
Nephrol Dial Transplant; 2002 May; 17(5):753-8. PubMed ID: 11981059
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of 11beta-hydroxysteroid dehydrogenase by bile acids in rats with cirrhosis.
Ackermann D; Vogt B; Escher G; Dick B; Reichen J; Frey BM; Frey FJ
Hepatology; 1999 Sep; 30(3):623-9. PubMed ID: 10462366
[TBL] [Abstract][Full Text] [Related]
3. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
[TBL] [Abstract][Full Text] [Related]
4. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
[TBL] [Abstract][Full Text] [Related]
5. Reduced activity of 11beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats.
Bistrup C; Thiesson HC; Jensen BL; Skøtt O
Acta Physiol Scand; 2005 Jun; 184(2):161-9. PubMed ID: 15916676
[TBL] [Abstract][Full Text] [Related]
6. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
Morris DJ; Brem AS; Odermatt A
J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
[TBL] [Abstract][Full Text] [Related]
7. Does a reduced 11 beta HSD type 2 activity contribute to sodium retention in the nephrotic syndrome?
Kerstens MN; Navis G; Dullaart RP
Nephrol Dial Transplant; 2003 Mar; 18(3):620; author reply 620-1. PubMed ID: 12584292
[No Abstract] [Full Text] [Related]
8. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
9. Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats.
Usa K; Singh RJ; Netzel BC; Liu Y; Raff H; Liang M
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F186-92. PubMed ID: 17389675
[TBL] [Abstract][Full Text] [Related]
10. 11beta-hydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation.
Hundertmark S; Dill A; Bühler H; Stevens P; Looman K; Ragosch V; Seckl JR; Lipka C
Horm Metab Res; 2002 Oct; 34(10):537-44. PubMed ID: 12439780
[TBL] [Abstract][Full Text] [Related]
11. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes.
Deschênes G; Doucet A
J Am Soc Nephrol; 2000 Apr; 11(4):604-615. PubMed ID: 10752519
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of 11beta-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint.
Ajilore OA; Sapolsky RM
Neuroendocrinology; 1999 Feb; 69(2):138-44. PubMed ID: 9986927
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo.
Vögeli I; Jung HH; Dick B; Erickson SK; Escher R; Funder JW; Frey FJ; Escher G
J Endocrinol; 2013 Nov; 219(2):119-29. PubMed ID: 24096962
[TBL] [Abstract][Full Text] [Related]
14. Furosemide inhibits 11beta-hydroxysteroid dehydrogenase type 2.
Fuster D; Escher G; Vogt B; Ackermann D; Dick B; Frey BM; Frey FJ
Endocrinology; 1998 Sep; 139(9):3849-54. PubMed ID: 9724039
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of stress, ACTH and corticosterone on testicular 11beta-hydroxysteroid dehydrogenase oxidative activity in rats and the possible mechanism of actions.
Nwe KH; Norhazlina AW; Hamid A; Morat PB; Khalid BA
Exp Clin Endocrinol Diabetes; 2000; 108(5):369-77. PubMed ID: 10989957
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids and 11 beta-hydroxysteroid dehydrogenase type 2 gene expression in the aging kidney.
Audigé A; Dick B; Frey BM; Frey FJ; Corman B; Vogt B
Eur J Clin Invest; 2002 Jun; 32(6):411-20. PubMed ID: 12059986
[TBL] [Abstract][Full Text] [Related]
17. The 11beta-hydroxysteroid dehydrogenases: functions and physiological effects.
Krozowski Z
Mol Cell Endocrinol; 1999 May; 151(1-2):121-7. PubMed ID: 10411326
[TBL] [Abstract][Full Text] [Related]
18. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of nitric oxide synthase in nephrotic syndrome: role of proteinuria.
Ni Z; Vaziri ND
Biochim Biophys Acta; 2003 Jul; 1638(2):129-37. PubMed ID: 12853118
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
